Because no difference in 14-3-3 ζ expression levels was found in MetS vs control cardiomyocytes (Fig 6E), other factors like Akt diminished activation, localization, or post-translational modifications, could be involved in the diminished Akt-14-3-3 ζ interaction. The gene discussed is AKT1; the disease is metabolic syndrome.